DNA Manufacturing Market
The DNA manufacturing market, also known as synthetic biology, involves the artificial creation of DNA molecules for research and therapeutic applications. The primary customers include pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs). Key growth drivers are the rising demand for personalized medicine, the rapid expansion of cell and gene therapies, and advancements in biotechnology that enable the development of novel vaccines and biologics.
CAGR
14.62%
Compound Annual Growth Rate
Current Value
$7.32B
Estimated 2026
Projected Value
$21.8B
By 2034